(ISSN 2771-9871)
Recent Progress in Nutrition (ISSN 2771-9871) is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. This periodical is devoted to publishing high-quality papers that describe the most significant and cutting-edge research in all areas of nutritional sciences. Its aim is to provide timely, authoritative introductions to current thinking, developments and research in carefully selected topics. Also, it aims to enhance the international exchange of scientific activities in nutritional science and human health.
Recent Progress in Nutrition publishes high quality intervention and observational studies in nutrition. High quality systematic reviews and meta-analyses are also welcome as are pilot studies with preliminary data and hypotheses generating studies. Emphasis is placed on understanding the relationship between nutrition and health and of the role of dietary patterns in health and disease.
Topics contain but are not limited to:
- Macronutrients
- Micronutrients
- Essential nutrients
- Bioactive nutrients
- Nutrient requirements
- Nutrient sources
- Human nutrition aspects
- Functional foods
- Nutraceuticals
- Health claims
- Public health
- Diet-related disorders
- Metabolic syndrome
- Malnutrition
- Nutritional supplements
- Sport nutrition
It publishes a variety of article types: Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.
There is no restriction on paper length, provided that the text is concise and comprehensive. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Publication Speed (median values for papers published in 2024): Submission to First Decision: 7.5 weeks; Submission to Acceptance: 15.5 weeks; Acceptance to Publication: 7 days (1-2 days of FREE language polishing included)
Special Issue
Effects of Marine Algae and Marine Natural Products in Metabolic Diseases
Submission Deadline: July 31, 2026 (Open) Submit Now
Guest Editor
Leonel Pereira, PhD
Associate Professor with Habilitation, Centre for Functional Ecology: Science for People & Planet, Marine Resources, Conservation and Technology—Marine Algae Lab, Department of Life Sciences, University of Coimbra, 3000-456 Coimbra, Portugal
Research Interests: Marine botany; phycology; biotechnology; biodiversity; ecology
Co-Editor
Ana Valado, PhD
1. Coordinator Professor, Polytechnic University of Coimbra, Rua da Misericórdia, Lagar dos Cortiços, S. Martinho do Bispo, 3045-093 Coimbra, Portugal
2. Research Center for Natural Resources, Environment and Society (CERNAS); H&TRC - Health & Technology Research Center; MARE – Marine and Environmental Sciences Centre / ARNET-Aquatic Research Network, University of Coimbra, 3000-456 Coimbra, Portugal
Research Interests: Carrageenans, total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides; multiple sclerosis; matrix metalloproteinases; MMP-9 polymorphism; IgG and IgM oligoclonal bands; cell adhesion molecules; aging, exercise, oxidative stress markers
About This Topic
This special issue focuses on the emerging role of marine algae and marine-derived natural products in the prevention and treatment of metabolic diseases. As global rates of obesity, type 2 diabetes, dyslipidemia, and non-alcoholic fatty liver disease continue to rise, there is an urgent need for novel, sustainable bioactive compounds with therapeutic potential. Marine algae—particularly red algae (Rhodophyta), brown algae (Phaeophyceae), and green algae (Chlorophyta)—have gained attention for their rich content of polysaccharides, polyphenols, sterols, peptides, and pigments that exhibit antioxidant, anti-inflammatory, and lipid-lowering properties. Recent studies have demonstrated that compounds such as fucoidan, laminarin, phlorotannins, carrageenans, and ulvans can modulate key metabolic pathways, improve insulin sensitivity, regulate lipid metabolism, and reduce systemic inflammation. Additionally, marine microalgae like diatoms and dinoflagellates are being investigated for their production of omega-3 fatty acids and other bioactive metabolites with potential metabolic benefits.
This issue invites contributions that explore:
Mechanistic insights into how marine algal compounds influence metabolic health;
Preclinical and clinical studies assessing efficacy and safety;
Advances in extraction, purification, and formulation of marine bioactive;
The role of marine nutraceuticals in personalized nutrition and functional food development...
By integrating marine biotechnology with nutritional science, this collection aims to highlight innovative strategies for combating metabolic disorders through ocean-derived resources.
Keywords
Marine algae; metabolic diseases; bioactive compounds; nutraceuticals; anti-inflammatory agents; lipid metabolism; functional foods
Manuscript Submission Information
Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (rpn@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.
Welcome your submission!
- Newsletter